Non-alcoholic fatty liver disease: a massive problem

被引：111

作者：

Day, Christopher P. ^{[1
]}

机构：

[1] Newcastle Univ, Fac Off, Fac Med Sci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

来源：

CLINICAL MEDICINE | 2011年 / 11卷 / 02期

关键词：

fatty liver; insulin resistance; obesity; steatohepatitis; steatosis; CONTROLLED-TRIAL; VITAMIN-E; CIRRHOSIS; PLACEBO; NAFLD;

D O I：

10.7861/clinmedicine.11-2-176

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：176 / 178

页数：3

共 18 条

[1]

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis [J].

Argo, Curtis K. ;

Northup, Patrick G. ;

Al-Osaimi, Abdullah M. S. ;

Caldwell, Stephen H. .

JOURNAL OF HEPATOLOGY, 2009, 51 (02) :371-379

[2]

Statins and hepatic steatosis: Perspectives from the Dallas Heart Study [J].

Browning, Jeffrey D. .

HEPATOLOGY, 2006, 44 (02) :466-471

[3]

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis [J].

Contos, MJ ;

Cales, W ;

Sterling, RK ;

Luketic, VA ;

Shiffman, ML ;

Mills, AS ;

Fisher, RA ;

Ham, J ;

Sanyal, AJ .

LIVER TRANSPLANTATION, 2001, 7 (04) :363-373

[4]

From fat to inflammation [J].

Day, CP .

GASTROENTEROLOGY, 2006, 130 (01) :207-210

[5]

Current and Future Therapeutic Strategies in NAFLD [J].

de Alwis, Nimantha Mark Wilfred ;

Day, Christopher Paul .

CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (17) :1958-1962

[6]

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis [J].

Dufour, Jean-Francois ;

Oneta, Carl M. ;

Gonvers, Jean-Jacques ;

Bihl, Florian ;

Cerny, Andreas ;

Cereda, Jean-Michel ;

Zala, Jean-Franco ;

Helbling, Beat ;

Steuerwald, Michael ;

Zimmermann, Arthur .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (12) :1537-1543

[7]

Long-term follow-up of patients with NAFLD and elevated liver enzymes [J].

Ekstedt, Mattias ;

Franzen, Lennart E. ;

Mathiesen, Ulrik L. ;

Thorelius, Lars ;

Holmqvist, Marika ;

Bodemar, Goran ;

Kechagias, Stergios .

HEPATOLOGY, 2006, 44 (04) :865-873

[8]

Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis: A Multicenter Validation Study [J].

Feldstein, Ariel E. ;

Wieckowska, Anna ;

Lopez, A. Rocio ;

Liu, Yao-Chang ;

Zein, Nizar N. ;

McCullough, Arthur J. .

HEPATOLOGY, 2009, 50 (04) :1072-1078

[9]

Hepatic histology in obese patients undergoing bariatric surgery [J].

Machado, Mariana ;

Marques-Vidal, Pedro ;

Cortez-Pinto, Helena .

JOURNAL OF HEPATOLOGY, 2006, 45 (04) :600-606

[10]

Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance [J].

Newton, J. L. ;

Jones, D. E. J. ;

Henderson, E. ;

Kane, L. ;

Wilton, K. ;

Burt, A. D. ;

Day, C. P. .

GUT, 2008, 57 (06) :807-813

← 1 2 →